Associated Papers
Exceptional response to Erlotinib monotherapy in EGFR Exon 19-deleted, KRAS wild-type, Chemo-refractory advanced pancreatic adenocarcinoma.
Park R et al.
Cancer Treatment and Research Communications, 2021
Select a paper to view details